Cisen Pharmaceutical

Cisen Pharmaceutical is a prominent chemicals manufacturing enterprise based in China, specializing in the pharmaceutical and healthcare sectors. Established in 1970 as the Jining City No.3 Pharmaceutical Factory, the organization underwent significant restructuring in 1998 to become Shandong Lukang Cisen Pharmaceutical Co., Ltd., before adopting its current identity as Cisen Pharmaceutical in 2011. The company operates as a comprehensive joint-equity enterprise, maintaining a robust presence in the regional market through its commitment to high-quality chemical and medical production standards.

The operational structure of Cisen Pharmaceutical is defined by its diverse portfolio of subsidiaries, which include Shandong Chenlong Pharmaceutical Co., Ltd., Cisen Fodu Pharmaceutical (Wenshang) Co., Ltd., and Beijing Cisen Huizhi Medicine Science & Technology Co., Ltd. These entities collectively support the company’s mission to deliver advanced pharmaceutical solutions. With a workforce ranging from 1,000-5,000 employees, the firm leverages specialized engineering and scientific expertise to maintain its competitive edge in the Asia-Pacific region. The company’s integrated approach to manufacturing ensures consistent quality across its various product lines, catering to both domestic and international healthcare demands.

Cisen Pharmaceutical demonstrates significant market scale, reporting annual revenue of $606.9M. This financial performance reflects the company's strategic focus on chemical manufacturing and pharmaceutical innovation. The organization continues to invest in research and development to expand its footprint within the global healthcare industry. Meet Cisen Pharmaceutical's team to learn more about the leadership and technical experts driving these operations. By prioritizing operational efficiency and scientific advancement, Cisen Pharmaceutical remains a key player in the pharmaceutical landscape.